Jubilant Pharmova Ltd - 530019 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Jubilant Pharmova Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Jubilant Pharmova Ltd - 530019 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
This is further to our letter dated September 22, 2021. Pursuant to the provisions of Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the following: 1. Details of the voting results in respect of the 43rd Annual General Meeting of the shareholders of the Company held on Wednesday, September 22, 2021 through Video Conferencing/ Other Audio Visual Means as Annexure 1. 2. Consolidated Scrutinizer''s Report pursuant to Section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014 as Annexure 2. We request you to take the same on records. Jubilant Pharmova Ltd - 530019 - Closure of Trading Window
Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from Friday, September 24, 2021 and the same shall remain closed till 48 hours after announcement of the financial results for the quarter ending September 30, 2021 to the Stock Exchanges. Accordingly, the Designated Persons have been intimated not to trade in the securities of the Company during the aforesaid period of closure of Trading Window. This is for your information and records. Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company shall be participating in Equirus Virtual Annual Conference, 2021 on September 27, 2021. We enclose details of the Investor/ Analyst for the same. The schedule may undergo change due to exigencies on the part of Investors/ Analysts/ Company. We also enclose the presentation to be used during the Virtual Conference. This is for your information and record.
Jubilant Life Sciences divests 10% in Safe Foods Corp for Rs 134 cr
Jubilant Life Sciences divested its entire stake in Safe Foods Corporation, consisting of 5,40,463 shares Jubilant Pharmova Ltd - 530019 - Shareholder Meeting / Postal Ballot-Outcome of AGM
The 43rd Annual General Meeting ('AGM') of Jubilant Pharmova Limited ('the Company') has been held today i.e. Wednesday, September 22, 2021 at 11.00 a.m. (IST) through Video Conferencing/ Other Audio Visual Means. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'SEBI Listing Regulations'), we submit the proceedings of 43rd AGM of the Company as Annexure 1. We request you to take the same on records. Jubilant Pharmova Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that a share certificate has been reported to be lost by the shareholder as per the attachment. The shareholder has requested for issuance of duplicate share certificate in lieu of the original. In pursuance of Section 124(6) of the Companies Act, 2013 read with the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, the above said shares have been transferred to the Investor Education and Protection Fund Authority (the 'IEPF Authority'). We propose to approve the claim of shareholder on receipt of the requisite documents for claiming these shares from the IEPF Authority. We request you to caution your members not to deal in or make any transaction in these shares. This is for your information and record. Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper advertisements for 43rd Annual General Meeting and e-voting information Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company shall be participating in an e-conference organized by Dolat Capital Market Pvt. Ltd. on Wednesday, September 1, 2021. We enclose details of the Investor/ Analyst for the same. The schedule may undergo change due to exigencies on the part of Investors/ Analysts/ Company. We also enclose the presentation to be used during the e-conference. Jubilant Pharmova Ltd - 530019 - Notice Of The 43Rd Annual General Meeting And Annual Report For The Financial Year 2020-21 Are Enclosed.
Notice of the 43rd Annual General Meeting and Annual Report for the Financial Year 2020-21 are enclosed.